118 related articles for article (PubMed ID: 2754842)
1. [Predictive value of serum aminoterminal type III procollagen peptide levels, serum laminin levels, and liver membrane antibodies for prognosis of chronic hepatitis].
Hirata R
Nihon Shokakibyo Gakkai Zasshi; 1989 Apr; 86(4):905-12. PubMed ID: 2754842
[TBL] [Abstract][Full Text] [Related]
2. Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis.
Gabrielli GB; Capra F; Casaril M; Squarzoni S; Tognella P; Dagradi R; De Maria E; Colombari R; Corrocher R; De Sandre G
Clin Chim Acta; 1997 Sep; 265(1):21-31. PubMed ID: 9352126
[TBL] [Abstract][Full Text] [Related]
3. Serum type III procollagen peptide and laminin (Lam-P1) detect alcoholic hepatitis in chronic alcohol abusers.
Annoni G; Colombo M; Cantaluppi MC; Khlat B; Lampertico P; Rojkind M
Hepatology; 1989 May; 9(5):693-7. PubMed ID: 2707736
[TBL] [Abstract][Full Text] [Related]
4. [Procollagen III and laminin in chronic viral hepatopathies].
Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
[TBL] [Abstract][Full Text] [Related]
5. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease.
Misaki M; Shima T; Yano Y; Sumita Y; Kano U; Murata T; Watanabe S; Suzuki S
Clin Chem; 1990 Mar; 36(3):522-4. PubMed ID: 2311224
[TBL] [Abstract][Full Text] [Related]
6. Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-alpha.
Teran JC; Mullen KD; Hoofnagle JH; McCullough AJ
Hepatology; 1994 Apr; 19(4):849-56. PubMed ID: 8138256
[TBL] [Abstract][Full Text] [Related]
7. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M
J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
9. Estimation of the production rates of serum aminoterminal propeptide of type III procollagen and laminin in human fibrotic liver.
Gressner AM; Kropf J; Tittor W
J Clin Chem Clin Biochem; 1987 Sep; 25(9):553-9. PubMed ID: 3681195
[TBL] [Abstract][Full Text] [Related]
10. Cryptogenic chronic active liver disease. Evaluation of serum aminoterminal peptide of type III procollagen as a marker of histological activity.
Diodati G; Bonetti P; Plebani M; Giacomini A; Rugge M; Realdi G; Burlina A
Ric Clin Lab; 1990; 20(4):253-9. PubMed ID: 2075377
[TBL] [Abstract][Full Text] [Related]
11. Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease.
Nouchi T; Worner TM; Sato S; Lieber CS
Alcohol Clin Exp Res; 1987 Jun; 11(3):287-91. PubMed ID: 3307495
[TBL] [Abstract][Full Text] [Related]
12. Biochemical markers of hepatic fibrosis.
Plebani M; Burlina A
Clin Biochem; 1991 Jun; 24(3):219-39. PubMed ID: 1651819
[TBL] [Abstract][Full Text] [Related]
13. Determination of the aminoterminal peptide of procollagen type III and laminin P1 in serum of patients with chronic liver disease.
Kárteszi M; Szalay L; Cornides A; Dávid K; Fehér J
Acta Med Hung; 1988; 45(3-4):277-86. PubMed ID: 3249655
[TBL] [Abstract][Full Text] [Related]
14. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake.
Niemelä O; Risteli J; Blake JE; Risteli L; Compton KV; Orrego H
Gastroenterology; 1990 Jun; 98(6):1612-9. PubMed ID: 1692550
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
[TBL] [Abstract][Full Text] [Related]
16. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.
Murawaki Y; Ikuta Y; Koda M; Kawasaki H
Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217
[TBL] [Abstract][Full Text] [Related]
17. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.
Guéchot J; Poupon RE; Giral P; Balkau B; Giboudeau J; Poupon R
J Hepatol; 1994 Mar; 20(3):388-93. PubMed ID: 8014451
[TBL] [Abstract][Full Text] [Related]
18. [Serum variations of 2 markers of fibrogenesis in chronic hepatitis C treated with alpha interferon].
Soresi M; Bascone F; Agate V; Carroccio A; Barresi E; Cartabellotta A; Aragona F; Montalto G
Recenti Prog Med; 1997 Feb; 88(2):73-6. PubMed ID: 9148370
[TBL] [Abstract][Full Text] [Related]
19. [Assay of serum collagen markers in chronic liver diseases and liver cancer].
Inoue T; Funaki N; Hatahara T; Igarashi S; Kaneko E; Tanaka H
Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1506-13. PubMed ID: 2170716
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers of hepatic fibrosis in primary biliary cirrhosis.
Plebani M; Giacomini A; Floreani A; Chiaramonte M; Soffiati G; Naccarato R; Burlina A
Ric Clin Lab; 1990; 20(4):269-74. PubMed ID: 2075379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
